Report - January 2017 · • GYN ONC • Oncology • ENT • Vascular Inial Targeted Speciales > $2 Billion TAM* -- U.S. Only Significant Market Growth Opportuni7es J-Plasma PlazXact

Please pass captcha verification before submit form